Stay updated on AbbVie Press Releases

Sign up to get notified when there's something new on the AbbVie Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the AbbVie Press Releases page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page now includes significant updates regarding AbbVie's acquisition of Capstan Therapeutics and the FDA's acceptance of Allergan Aesthetics' application for SKINVIVE, both of which are crucial for understanding AbbVie's strategic direction in patient care and product offerings.
    Difference
    77%
    Check dated 2025-07-04T03:50:22.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The page now includes an announcement of AbbVie's quarterly dividend declaration dated June 20, 2025, while the previous announcement regarding the FDA approval for MAVYRET has been removed.
    Difference
    22%
    Check dated 2025-06-27T00:29:00.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The webpage has added significant updates regarding AbbVie's clinical trial results and product announcements, while also removing older content related to BOTOX® Cosmetic and Allergan Aesthetics training centers.
    Difference
    84%
    Check dated 2025-06-19T19:26:57.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now highlights the U.S. FDA's approval of AbbVie's MAVYRET® as the first and only treatment for acute Hepatitis C, while removing previous mentions of AbbVie's partnership with the Chicago Cubs and the approval of RINVOQ® for Giant Cell Arteritis.
    Difference
    27%
    Check dated 2025-06-12T15:25:13.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The webpage has added significant announcements regarding AbbVie's initiatives and partnerships, including the launch of the Second Annual AbbVie Migraine Career Catalyst Award™ Contest and a partnership with the Chicago Cubs. Additionally, it has removed several past announcements related to AbbVie's financial results and product approvals.
    Difference
    79%
    Check dated 2025-06-05T08:12:28.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The webpage now features new data from AbbVie regarding difficult-to-treat solid tumors and blood cancers presented at ASCO 2025, while previous announcements about AbbVie's participation in the Bank of America Securities Healthcare Conference and the first-quarter earnings call have been removed.
    Difference
    31%
    Check dated 2025-05-29T05:45:15.000Z thumbnail image

Stay in the know with updates to AbbVie Press Releases

Enter your email address, and we'll notify you when there's something new on the AbbVie Press Releases page.